Valeo Financial Advisors, LLC Innoviva, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$10.33 - $14.49 $33,334 - $46,759	-3,227 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$10.28 - $14.38 $37,398 - $52,314	-3,638 Reduced 52.99%	3,227 $46,000
Q2 2019 Jul 10, 2019	BUY	$13.1 - $14.95 $89,931 - $102,631	6,865 New	6,865 $100,000
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $2,083 - $2,726	-155 Closed	0 $0
Q1 2018 Apr 12, 2018	BUY	$13.8 - $16.99 $2,139 - $2,633	155 New	155 $3,000

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.